USC Stevens Center News

Dr. Erin Overstreet has been named the Executive Director of the USC Stevens Center for Innovation. With more than 16 years of experience in academic technology transfer, licensing, industry partnerships, and research administration, she oversees the day-to-day operations of the office, manages the university’s extensive IP portfolio, facilitates collaboration between university researchers and industry partners,

At the last Association for University Technology Managers (AUTM) Western Region Meeting, Interim Associate Vice President of Research Strategy and Innovation, Steven Moldin, and Senior Technology Licensing Manager, Bonnie Phan Wolf, spoke on two panels. Steve’s talk was titled “Core R&D Facilities, IP, and Startups: How Universities Use Research Infrastructure Commons to Drive Startups,

From research focusing on how AI can improve officer interactions with the public to research of sedentary time correlating with higher risks of dementia, innovation was constant in the month of September.

USC Stevens Center announces the execution of an exclusive, worldwide license between biotechnology company AcuraStem and biopharmaceutical company Takeda Pharmaceuticals.

A collaboration between the USC Stevens Center and leadership from IntelliMicro Medical Co. and Golden Eye Bionics took place to discuss the commercialization of medical devices.

From research studying how to change our inability to recover hearing ability to research showing underrepresented minority groups in Alzheimer’s neuroimaging research, innovation was thriving in the month of August.

This year, various USC research has shed insight on the subject of vaccines, their importance, and how they can help prevent serious and deadly diseases and illnesses.

USC-supported startup Regenerative Patch Technologies (RPT) was awarded an estimated $12.4 million from the California Institute for Regenerative Medicine (CIRM), a state institute that supports research to address unmet medical needs.